Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Akt-mediated transforming growth factor-β1-induced epithelial-mesenchymal transition in cultured human esophageal squamous cancer cells.

Xuan X, Zeng Q, Li Y, Gao Y, Wang F, Zhang H, Wang Z, He H, Li S.

Cancer Gene Ther. 2014 Jun;21(6):238-45. doi: 10.1038/cgt.2014.23. Epub 2014 May 30.

PMID:
24874843
2.

Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway.

Zhang HY, Wang ZQ, Li YY, Wang F, Zeng QR, Gao Y, Xuan XY, Li SS.

Oncol Rep. 2014 Nov;32(5):2134-42. doi: 10.3892/or.2014.3453. Epub 2014 Aug 29.

PMID:
25175594
3.

TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.

Pang L, Li Q, Wei C, Zou H, Li S, Cao W, He J, Zhou Y, Ju X, Lan J, Wei Y, Wang C, Zhao W, Hu J, Jia W, Qi Y, Liu F, Jiang J, Li L, Zhao J, Liang W, Xie J, Li F.

PLoS One. 2014 Dec 2;9(12):e112300. doi: 10.1371/journal.pone.0112300. eCollection 2014.

4.

TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.

Bu F, Liu X, Li J, Chen S, Tong X, Ma C, Mao H, Pan F, Li X, Chen B, Xu L, Li E, Kou G, Han J, Guo S, Zhao J, Guo Y.

Oncotarget. 2015 Feb 10;6(4):2120-33.

5.

EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.

Sato F, Kubota Y, Natsuizaka M, Maehara O, Hatanaka Y, Marukawa K, Terashita K, Suda G, Ohnishi S, Shimizu Y, Komatsu Y, Ohashi S, Kagawa S, Kinugasa H, Whelan KA, Nakagawa H, Sakamoto N.

Cancer Biol Ther. 2015;16(6):933-40. doi: 10.1080/15384047.2015.1040959. Epub 2015 Apr 21.

7.

Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways.

Chen XF, Zhang HJ, Wang HB, Zhu J, Zhou WY, Zhang H, Zhao MC, Su JM, Gao W, Zhang L, Fei K, Zhang HT, Wang HY.

Mol Biol Rep. 2012 Apr;39(4):3549-56. doi: 10.1007/s11033-011-1128-0. Epub 2011 Jun 29.

PMID:
21713404
8.

Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.

Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J, Li Q.

BMC Cancer. 2015 Mar 5;15:97. doi: 10.1186/s12885-015-1119-y.

9.

Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.

Chiba T, Ishisaki A, Kyakumoto S, Shibata T, Yamada H, Kamo M.

Oncol Rep. 2017 Feb;37(2):713-720. doi: 10.3892/or.2016.5338. Epub 2016 Dec 28.

10.

S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.

Zhang K, Zhang M, Zhao H, Yan B, Zhang D, Liang J.

Dis Esophagus. 2012 Nov-Dec;25(8):731-9. doi: 10.1111/j.1442-2050.2012.01323.x. Epub 2012 Mar 27.

PMID:
22458600
11.

Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.

Park NR, Cha JH, Jang JW, Bae SH, Jang B, Kim JH, Hur W, Choi JY, Yoon SK.

Biochem Biophys Res Commun. 2016 Sep 2;477(4):568-74. doi: 10.1016/j.bbrc.2016.06.077. Epub 2016 Jun 16.

PMID:
27320862
12.

Transforming growth factor-β1 induces epithelial-mesenchymal transition and integrin α3β1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug.

Saito D, Kyakumoto S, Chosa N, Ibi M, Takahashi N, Okubo N, Sawada S, Ishisaki A, Kamo M.

J Biochem. 2013 Mar;153(3):303-15. doi: 10.1093/jb/mvs144. Epub 2012 Dec 17.

PMID:
23248240
13.

The glioma-associated oncogene homolog 1 promotes epithelial--mesenchymal transition in human esophageal squamous cell cancer by inhibiting E-cadherin via Snail.

Min S, Xiaoyan X, Fanghui P, Yamei W, Xiaoli Y, Feng W.

Cancer Gene Ther. 2013 Jul;20(7):379-85. doi: 10.1038/cgt.2013.36. Epub 2013 Jun 21.

PMID:
23788111
14.

Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma.

Nakayama A, Ninomiya I, Harada S, Tsukada T, Okamoto K, Nakanuma S, Sakai S, Makino I, Kinoshita J, Hayashi H, Oyama K, Miyashita T, Tajima H, Takamura H, Fushida S, Ohta T.

Int J Oncol. 2016 Nov;49(5):1890-1898. doi: 10.3892/ijo.2016.3676. Epub 2016 Aug 31.

PMID:
27599468
15.

Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial-mesenchymal transition in esophageal squamous cell carcinoma.

Bai X, Li YY, Zhang HY, Wang F, He HL, Yao JC, Liu L, Li SS.

Onco Targets Ther. 2017 Jun 2;10:2837-2847. doi: 10.2147/OTT.S134813. eCollection 2017.

16.

TWEAK enhances TGF-β-induced epithelial-mesenchymal transition in human bronchial epithelial cells.

Itoigawa Y, Harada N, Harada S, Katsura Y, Makino F, Ito J, Nurwidya F, Kato M, Takahashi F, Atsuta R, Takahashi K.

Respir Res. 2015 Apr 8;16:48. doi: 10.1186/s12931-015-0207-5.

17.

PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.

Zhang H, Sun JD, Yan LJ, Zhao XP.

Biochem Biophys Res Commun. 2016 Sep 16;478(2):845-51. doi: 10.1016/j.bbrc.2016.08.035. Epub 2016 Aug 6.

PMID:
27507215
18.

Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.

Yang T, Chen M, Sun T.

Cell Physiol Biochem. 2013;31(6):863-74. doi: 10.1159/000350104. Epub 2013 Jun 11.

19.

Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma.

Ogunwobi OO, Wang T, Zhang L, Liu C.

J Gastroenterol Hepatol. 2012 Mar;27(3):566-78. doi: 10.1111/j.1440-1746.2011.06980.x.

20.

Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.

Zhang HF, Alshareef A, Wu C, Li S, Jiao JW, Cao HH, Lai R, Xu LY, Li EM.

Oncotarget. 2015 Oct 6;6(30):28949-60. doi: 10.18632/oncotarget.5027.

Supplemental Content

Support Center